Misonidazole
Showing 1 - 19 of 19
Head Neck Cancer Trial in United States (fluorine-18-labeled fluoro-misonidazole (18F-FMISO), 18F-FMISO PET scan, MRI)
Active, not recruiting
- Head and Neck Cancer
- fluorine-18-labeled fluoro-misonidazole (18F-FMISO)
- +3 more
-
Basking Ridge, New Jersey
- +4 more
Jul 8, 2022
Malignant Brain Tumor Trial in Portland (¹8F-Fluoromisonidazole, Computed Tomography, Magnetic Resonance Imaging)
Recruiting
- Malignant Brain Neoplasm
- ¹⁸F-Fluoromisonidazole
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Feb 19, 2022
BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial in
Recruiting
- BCLC Stage A Hepatocellular Carcinoma
- +3 more
- 18F-Fluoromisonidazole
- +3 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
May 25, 2022
Colorectal Cancer Trial in New York (Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission)
Withdrawn
- Colorectal Cancer
- Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Apr 6, 2020
Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in
Active, not recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +24 more
- 18F-Fluoromisonidazole
- +4 more
-
La Jolla, California
- +15 more
Jan 3, 2023
Stage III Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7, Stage IIIB Lung Non-Small Cell
Active, not recruiting
- Stage III Lung Non-Small Cell Cancer AJCC v7
- +2 more
- 18F-Fluoromisonidazole
- +8 more
-
Palo Alto, California
- +30 more
Apr 28, 2021
Non-Small-Cell-Lung Cancer (NSCLC) Trial in New York (18F-FMISO, PET/CT)
Active, not recruiting
- Non-Small-Cell-Lung Cancer (NSCLC)
- 18F-FMISO
- PET/CT
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 3, 2022
Adult Liver Carcinoma, Liver Cirrhosis Trial in Palo Alto (drug, procedure, diagnostic test)
Completed
- Adult Liver Carcinoma
- Liver Cirrhosis
- 18F-Fluoromisonidazole
- +3 more
-
Palo Alto, CaliforniaVA Palo Alto Healthcare System
May 1, 2019
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma Trial in United States (FMISO, MRI, PET)
Completed
- Adult Giant Cell Glioblastoma
- +2 more
- FMISO
- +3 more
-
Birmingham, Alabama
- +13 more
Mar 14, 2019
Prostate Cancer Trial in Toulouse (F-MISO PET imaging)
Withdrawn
- Prostate Cancer
- F-MISO PET imaging
-
Toulouse, FranceCentre de Lutte Contre le Cancer
Nov 25, 2019
Cervix Cancer Trial in Maastricht (injection with [18F] HX4 and PET imaging)
Terminated
- Cervix Cancer
- injection with [18F] HX4 and PET imaging
-
Maastricht, NetherlandsMAASTRO clinic
Mar 7, 2019
Head Neck Cancer Trial in Maastricht (Injection of [18F]HX4)
Completed
- Cancer of the Head and Neck
- Injection of [18F]HX4
-
Maastricht, NetherlandsMaastricht Radiation Oncology (MAASTRO clinic)
Jan 27, 2017
Melanoma, Skin Cancer Trial (Pimonidazole HCl (Hypoxyprobe™-1), Optional 18F-FMISO PET scan (18F-fluoromisonidazole), Surgical
Withdrawn
- Melanoma
- Skin Cancer
- Pimonidazole hydrochloride (Hypoxyprobe™-1)
- +2 more
- (no location specified)
May 6, 2016
Validation of 18F-MISO-PET and 18F-FLT-PET
Terminated
- Head and Neck Neoplasms
- 18F-FLT and 18F-MISO-PET
-
Nijmegen, Gelderland, NetherlandsUMC St Radboud, Department of Radiotherapy
May 6, 2015
Rectal Adenocarcinoma Trial in Toulouse (Pelvic MRI and F MISO TEP)
Terminated
- Rectal Adenocarcinoma
- Pelvic MRI and F MISO TEP
-
Toulouse, FranceCHU Toulouse
Jan 22, 2013
Fixation of Various Vectors in PET/CT inWith Lung Cancer Before
Completed
- Bronchial Neoplasms
- Carcinoma, Non-Small-Cell Lung
-
Rouen, Hate Normandie, FranceCentre Henri Becquerel
Dec 15, 2010